KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Assets Average (2019 - 2025)

Historic Assets Average for Moderna (MRNA) over the last 7 years, with Q3 2025 value amounting to $12.1 billion.

  • Moderna's Assets Average fell 2330.78% to $12.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 billion, marking a year-over-year decrease of 2330.78%. This contributed to the annual value of $16.3 billion for FY2024, which is 2645.65% down from last year.
  • Per Moderna's latest filing, its Assets Average stood at $12.1 billion for Q3 2025, which was down 2330.78% from $12.4 billion recorded in Q2 2025.
  • Moderna's Assets Average's 5-year high stood at $26.8 billion during Q2 2022, with a 5-year trough of $10.0 billion in Q1 2021.
  • In the last 5 years, Moderna's Assets Average had a median value of $18.5 billion in 2021 and averaged $19.0 billion.
  • Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 44774.96% in 2021, then plummeted by 2966.61% in 2024.
  • Over the past 5 years, Moderna's Assets Average (Quarter) stood at $22.8 billion in 2021, then increased by 13.87% to $26.0 billion in 2022, then fell by 27.04% to $18.9 billion in 2023, then dropped by 20.94% to $15.0 billion in 2024, then decreased by 19.37% to $12.1 billion in 2025.
  • Its Assets Average was $12.1 billion in Q3 2025, compared to $12.4 billion in Q2 2025 and $13.4 billion in Q1 2025.